Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: J Neuroimmunol. 2018 Mar 17;319:80–92. doi: 10.1016/j.jneuroim.2018.03.009

Fig. 2.

Fig. 2

GM-CSF administration improves memory retention in AD mice. Non-Tg mice treated with PBS (Non-Tg/PBS) or GM-CSF (Non-Tg/GM-CSF) and AD mice treated with PBS (AD/PBS) or GM-CSF (AD/GM-CSF) were tested by the RAWM task at 7 months of age. Non-Tg mice served as normal behavior controls for the spatial learning task. The compiled mean errors for day 4–6 are shown. Data are presented as mean number of errors ± SEM (n = 8 per group), and **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001 compared to AD/PBS treated group as determined by two-way ANOVA and Bonferroni post-hoc test.